CN106434558B - Method for separating, culturing and verifying functions of fish mononuclear/phagocyte - Google Patents
Method for separating, culturing and verifying functions of fish mononuclear/phagocyte Download PDFInfo
- Publication number
- CN106434558B CN106434558B CN201610775091.5A CN201610775091A CN106434558B CN 106434558 B CN106434558 B CN 106434558B CN 201610775091 A CN201610775091 A CN 201610775091A CN 106434558 B CN106434558 B CN 106434558B
- Authority
- CN
- China
- Prior art keywords
- phagocytes
- fish
- culture
- monocytes
- culturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000001539 phagocyte Anatomy 0.000 title claims abstract description 57
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000012258 culturing Methods 0.000 title claims description 17
- 230000006870 function Effects 0.000 title abstract description 12
- 210000001616 monocyte Anatomy 0.000 claims abstract description 41
- 210000004027 cell Anatomy 0.000 claims abstract description 40
- 210000005087 mononuclear cell Anatomy 0.000 claims description 22
- 210000004698 lymphocyte Anatomy 0.000 claims description 21
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 13
- 239000007853 buffer solution Substances 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 9
- 230000001464 adherent effect Effects 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 230000005484 gravity Effects 0.000 claims description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000012894 fetal calf serum Substances 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- 238000002955 isolation Methods 0.000 claims description 4
- 210000005259 peripheral blood Anatomy 0.000 claims description 4
- 239000011886 peripheral blood Substances 0.000 claims description 4
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 11
- 210000003743 erythrocyte Anatomy 0.000 abstract description 10
- 238000000338 in vitro Methods 0.000 abstract description 9
- 230000019254 respiratory burst Effects 0.000 abstract description 9
- 230000000242 pagocytic effect Effects 0.000 abstract description 7
- 241000287828 Gallus gallus Species 0.000 abstract description 6
- 238000001514 detection method Methods 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 238000012795 verification Methods 0.000 abstract description 4
- 230000009466 transformation Effects 0.000 abstract description 3
- 210000000349 chromosome Anatomy 0.000 description 11
- 241001014350 Cynoglossus semilaevis Species 0.000 description 10
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000001788 irregular Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 241000544286 Vibrio anguillarum Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 210000000805 cytoplasm Anatomy 0.000 description 4
- 210000003714 granulocyte Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000000432 density-gradient centrifugation Methods 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- FNEZBBILNYNQGC-UHFFFAOYSA-N methyl 2-(3,6-diamino-9h-xanthen-9-yl)benzoate Chemical compound COC(=O)C1=CC=CC=C1C1C2=CC=C(N)C=C2OC2=CC(N)=CC=C21 FNEZBBILNYNQGC-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002644 phorbol ester Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 238000002738 Giemsa staining Methods 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000024321 chromosome segregation Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 229940047120 colony stimulating factors Drugs 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000002288 golgi apparatus Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 108010088880 plasmagel Proteins 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000001243 pseudopodia Anatomy 0.000 description 1
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The application provides a separation, culture, transformation and function verification method for fish monocytes, which successfully obtains fish phagocytes by optimizing culture parameters and conditions; phagocytic function of phagocytic cells of fish obtained by phagocytic cell phagocytic exogenous chicken erythrocyte and in vitro respiratory burst detection. The method of the application realizes in vitro separation, transformation, continuous culture and the like of the fish phagocytes, has the advantages of less required samples, short operation time, simple flow and high accuracy, and can be widely applied to research of fish immune-related functions on the cell level.
Description
Technical Field
The application belongs to the technical field of biological cell culture, and particularly relates to a method for separating and culturing fish mononuclear/phagocyte and verifying functions.
Background
With the recent expansion of the cultivation scale, the development of the cultivation industry of fishes with high economic value (such as cynoglossus semilaevis) is seriously hampered by the disease problem caused by harmful bacteria such as vibrio anguillarum and the like. At present, no effective immune control technology and method exist, and the occurrence of diseases is still controlled by adopting traditional modes such as chemical medicines, antibiotics and the like. Peripheral blood mononuclear cells (precursors of phagocytes) are an important component of fish humoral immunity and play an important role in the processes of fish specific immunity and nonspecific immunity. At present, the immune function research of fish monocytes such as cynoglossus semilaevis still belongs to a starting stage, the action mechanism of the fish monocytes is not clear, and the cynoglossus semilaevis phagocytes which can be continuously cultured for cell function research are not obtained so far.
The precursor of phagocytes is mononuclear cells, which are spherical, pear-shaped or irregular, and have elongated pseudopodiform cytoprocess on their surface. The nuclei of monocytes are smaller, kidney-shaped or horseshoe-shaped, often on one side, with a nuclear to cytoplasmic ratio <1. In Giemsa staining, the nuclei of monocytes are in a grid. Under transmission electron microscopy, there are many mitochondria in the cytoplasm, and sometimes golgi apparatus, rough endoplasmic reticulum, ribosome, phagocytized senescent cells or nuclei thereof, and the like.
Monocytes have a strong phagocytic capacity and exert important nonspecific phagocytic functions in the fish organism. It can capture and fuse foreign substances and its own senescent cells through the pseudopodiform cell process and can produce active deformation movements. In addition, monocytes are also very sensitive to environmental changes, and in fish living in severely contaminated waters, the monocyte content can be approximately 50 times higher than normal. The fish may also cause a sudden increase in the number of monocytes after infection by parasites or artificial injection of substances such as colloidal carbon particles. Therefore, by measuring the quantity of the fish monocytes, the health condition of the fish and the environmental quality of the living water area can be primarily known.
Monocytes and phagocytes transformed with monocytes play an important role in the resistance and defense against pathogen infection, and in particular play a great role in intracellular pathogen defense. In addition, phagocytes are also present in fragments after phagocytosis by phagocytes, and they play a vital role in innate immunity and acquired immunity. They all exhibit different functions, morphologies, and metabolic effects, depending on the environment within the tissue and the different differentiation and activity stages they are in. Monocytes are derived from hematopoietic progenitor cells in the bone marrow, which migrate through the blood circulation of 2-3 d to individual tissues, differentiating into phagocytes in the tissues.
The cell which can survive in vitro for a long time and can be subcultured is the basis for performing researches such as cell immunology. Common monocyte isolation methods include: plasma gel method, standard Ficoll method and Percoll-paque method. But these methods alone utilize a mixed suspension that is prone to lymphocyte, granulocyte, platelet and various erythrocytes.
Disclosure of Invention
Aiming at overcoming the defects of the prior art, the application provides a separation, culture, transformation and function verification method for fish monocytes. The specific scheme is as follows:
a method for separating and culturing fish mononuclear/phagocyte, comprising the steps of:
step one: isolation and culture of monocytes;
step two: in vitro culture of monocytes induced as phagocytes;
further, in the first step, the specific steps are as follows:
s1, extracting peripheral blood of fish, and uniformly diluting and mixing whole blood with Hank' S buffer solution in a ratio of 1:2.5-1:3 to obtain diluted blood;
s2, taking lymphocyte separation liquid with the weight of 1.5 times of diluted blood and the specific gravity of 1.05-1.09 and release blood in a centrifuge tube;
s2, centrifuging for 18-21 minutes at 1800-2100rpm of a horizontal centrifuge, and collecting a mononuclear cell layer;
s4, adding 4-5 times of Hank' S buffer solution to wash for 2 times, centrifuging at 900-1100rpm for 5min, and collecting cell sediment;
s5, re-suspending in a DMEM complete medium, inoculating in a culture flask, and placing in a 24 ℃ incubator for culturing 3h;
s6, washing the supernatant with Hank' S buffer solution, and adding fresh culture medium to continue culturing the adherent cells;
s7, centrifuging to obtain a monocyte layer, namely lymphocyte and monocyte;
s8, re-suspending the separated mononuclear cells in a complete DMEM medium containing 10-15% of fetal calf serum and added with an adherence promoting growth factor bFGF;
s9, after culturing for 2-4 hours, washing away suspended lymphocytes to obtain adherent mononuclear cells.
Further, in the second step, the specific steps are as follows:
s1, adding 10-15% of lymphocytes in a complete DMEM culture medium containing mononuclear cells and 15% of fetal calf serum;
s2, changing fresh DMEM complete medium for half a day, and culturing for 3-12 days.
A method of functional verification of a mononuclear/phagocyte cell comprising the steps of:
s1, incubating 50ul of the separated mononuclear cell with phorbol ester (PMA) stimulant at 23-25 ℃ for 15min;
s2, adding 25ul of dihydrorhodamine, and incubating for 5min at 24 ℃ in a dark place;
s3, washing for 2 times by adopting PBS buffer solution;
s4, centrifuging at 1500rpm for 5min;
s5, removing supernatant, and adding 0.5ml of PBS buffer solution to resuspend cells;
s6, detecting by using an up-flow cytometer.
The beneficial effects of the application are as follows:
according to the application, the cell separation liquid is used for density gradient centrifugation, the fish mononuclear cells (phagocytes) are successfully separated and purified by correcting various parameters and experimental conditions in the experimental process, and then the cynoglossus semilaevis mononuclear cells are cultured for more than one week in an adherent growth mode by optimizing nutrition and culture conditions, so that the method can be suitable for subsequent experiments. The application successfully detects respiratory burst of phagocytes and provides materials for further researching biological characteristics and immunological functions of mononuclear/phagocytes.
Drawings
FIG. 1 shows the monocyte morphology (A: 12h for culture; B: 24h for culture; C: 32h for culture; D: 38h for culture) in the examples of the present application;
FIG. 2 is a graph showing the growth of monocytes in accordance with the present application;
FIG. 3 is a graph showing respiratory burst detection under PMA stimulation in an embodiment of the present application;
FIG. 4 shows respiratory burst detection after Vibrio anguillarum infection in an embodiment of the application;
FIG. 5 shows monocytes and phagocytes according to an embodiment of the present application;
FIG. 6 shows several forms of phagocytes according to embodiments of the application;
FIG. 7 is an illustration of an aged phagocyte according to an embodiment of the present application;
FIG. 8 shows giemsa stained phagocytes according to an embodiment of the application;
FIG. 9 shows phagocytes that phagocytose chicken erythrocytes in an embodiment of the application;
FIG. 10 shows the metaphase of chromosome division of phagocytes on day 5 of culture in examples of the present application;
FIG. 11 shows the distribution of the chromosome number of phagocytes in the examples of the present application.
Detailed Description
In order to make the technical solution of the present application better understood by those skilled in the art, the technical solution of the present application will be clearly and completely described in the following with reference to the accompanying drawings, and based on the embodiments of the present application, other similar embodiments obtained by those skilled in the art without making any inventive effort should be included in the scope of protection of the present application.
The present application has been completed based on the following findings by the inventors: in fish peripheral blood cells, various cells are caused to undergo density gradient centrifugation due to differences in morphology and weight: erythrocytes and granulocytes with the greatest specific gravity, secondary mononuclear cells (including lymphocytes and monocytes), and thrombus cells with the smallest specific gravity are at different levels when separated. Therefore, by correcting the centrifugal speed, the centrifugal time, and the density ratio of the separation liquid, the cells can be separated by the density gradient centrifugation method. After centrifugation, the plasma layer can be divided into a transparent plasma layer and a white membrane-shaped mononuclear cell layer from top to bottom, the transparent separation liquid layer has the greatest specific gravity of granulocytes and erythrocytes, and the granulocytes and erythrocytes are sunk at the lowest part, so that the purpose of coarse separation is achieved; secondly, the difference exists between the ability of the lymphocytes and the phagocytes to adhere when the lymphocytes and the phagocytes in the tunica albuginea are cultured in the culture medium, so that the phagocytes can be successfully separated by not distinguishing the adhesion force, and the serum in the cell culture medium can promote the cell growth and is beneficial to cell adhesion, so that the phagocytes and the lymphocytes can be effectively separated by correcting the addition amount and the addition timing of the serum and by correcting the concentration of pancreatin after a certain time of culture; in addition, in vitro monocytes are activated by phagocyte colony stimulating factors (M-CSF) to phagocytes, which are characterized by phagocytic activity, respiratory burst, etc. This is the largest difference between lymphocytes and phagocytes, which can be identified by this condition.
Examples: taking cynoglossus semilaevis as an example, the application discloses a method for culturing fish phagocytes, verifying functions and transforming the phagocytes.
1. Separation and culture of cynoglossus semilaevis peripheral blood mononuclear cells
The cynoglossus semilaevis is anesthetized in ice water, 70% alcohol cotton balls wipe back tail veins, heparin anticoagulation tubes extract 2ml of peripheral blood, whole blood and Hank's buffer solution are diluted and mixed uniformly in an ultra-clean workbench, 3ml of lymphocyte separation solution with the specific gravity of 1.05-1.09 is taken in a 15ml centrifuge tube, 2ml of diluted blood is added to centrifuge for 18-21 minutes at 1800-2100rpm of a horizontal centrifuge, a mononuclear cell layer is collected, hank's buffer solution with the volume of 4-5 times is added to wash for 2 times, centrifugation is carried out at 900-1100rpm for 5 minutes to collect cell sediment, the cell sediment is resuspended in DMEM complete medium, the cell sediment is inoculated in a culture flask and placed in a 24 ℃ incubator to be cultured for 3 hours, hank's buffer solution is added to wash out supernatant, adherent cells are continuously cultured, fresh complete DMEM medium is replaced by half of the specific gravity every other day, and cell morphology is observed under an inverted microscope.
According to the characteristic that lymphocytes are not adhered to the outside of a body and are in a suspension state, and the monocytes are very easy to adhere to the wall, the separated mononuclear cells are resuspended in a complete DMEM (medium) containing 10-15% of fetal calf serum and added with an adhesion promoting growth factor bFGF, and the suspension lymphocytes are washed after 2-4h of culture, so that the adhered monocytes are obtained, and the monocytes can be cultured for more than one week and are shown in a morphological figure 1 under an inverted microscope. The cell body diameter is 12-16 mu m, the cells are in irregular shapes such as a sector shape, a polygon shape and the like, the cell mass is high, and the adhesive property is strong.
MTT method for detecting monocyte in vitro growth curve
The isolated monocytes were inoculated into 96-well culture plates and incubated at 24℃in an incubator. 50ul of MTT solution is added at 0h, 6h, 12h, 18h, 24h, 36h and 48h respectively, and the incubator continues to incubate for 4h. The supernatant was washed, 150ul of DMSO was added to each well, the plate was shaken for 10min, and the optical density of each well was measured by an ELISA reader at 570nm and repeated three times. The in vitro growth curve of cynoglossus semilaevis mononuclear cells detected by MTT method is shown in figure 2. The cells can be well adhered after being inoculated for 3 hours, proliferate rapidly after 12 hours, the cell quantity is basically stable after 48 hours, and the cells show aggregation growth phenomenon and irregular morphology.
3. Determination of monocyte respiratory burst
Adding phorbol ester (PMA) stimulant 50ul to the separated mononuclear cells, incubating for 15min at 23-25 ℃, adding dihydrorhodamine 25ul, incubating for 5min at 24 ℃ in a dark place, washing for 2 times by using PBS buffer, centrifuging at 1500rpm for 5min, removing supernatant, adding 0.5ml of PBS buffer to resuspend cells, detecting by using an upflow cytometer, and setting a control group, wherein the mononuclear cells are not added in the control group; meanwhile, the cynoglossus semilaevis is directly infected by vibrio anguillarum: an experimental group and a control group were set, and the experimental group was 3.18X10 5 The cynoglossus semilaevis is intraperitoneally injected with CFU/g (semi-lethal dose, LD 50), and the control group is injected with PBS at a dose corresponding to the body weight in the reference experimental group. After 24h, the peripheral blood of the experimental group fish and the control group fish are respectively aseptically taken, mononuclear cells are obtained by separation according to the method, 50ul of the phorbol ester (PMA) stimulant is added, incubation is carried out for 15min at 24 ℃, 25ul of the dihydrorhodamine is added, incubation is carried out for 5min at 24 ℃ in a dark place, PBS buffer is used for washing for 2 times, centrifugation is carried out at 1500rpm for 5min, supernatant is removed, 0.5ml of PBS buffer is added for resuspension of cells, and the cells are respectively detected by a flow cytometer.
The flow cytometer detection results are shown in fig. 3, wherein the proportion of cells which fluoresce in the normal cell control group is 0.4%, and the proportion of cells which fluoresce in the experimental group under the stimulation of PMA is 80.67%, which indicates that the separated monocytes have respiratory burst function. The respiratory burst of mononuclear cells isolated after Vibrio anguillarum infection is shown in FIG. 4, the proportion of fluorescing cells in the control group is 4.18%, and the proportion of fluorescing cells in the experimental group is 83.81%, which indicates that the pathogenic stimulus significantly enhances the respiratory burst intensity of mononuclear cells.
4. In vitro culture of monocytes induced to phagocytes
Monocytes and lymphocytes are co-cultured in vitro to stimulate activation of monocytes to become typical phagocytes. Thus, 5-10% by number of lymphocytes were added to a complete DMEM medium containing 15% fetal bovine serum, and half a day apart was exchanged for fresh DMEM complete medium. After 3d of cell culture, the cells were observed under an inverted phase contrast microscope (see FIG. 5). Phagocytes adhere to the wall, the cells stretch and firmly adhere, the volume is obviously increased, the irregular shape is gradually changed into an oval shape, the shape is a omelette shape, and a few of phagocytes are long fusiform shapes. There may be partial fusion between cells, visible platelike pseudopodia and protrusion around or at both poles, no apparent proliferation of cells (FIG. 6), culturing to 13 days, and aging of phagocytes (FIG. 7).
5. Phagocyte staining observations
Culturing phagocytes until the phagocytes are cultured for 7 days, washing off lymphocytes suspended in a culture flask by using PBS buffer solution, adding methanol to fix the adherent phagocytes, dripping diluted giemsa staining solution to cover the bottom of the flask, staining at room temperature for 20min, sucking the staining solution, flushing the adherent cells by using distilled water, and observing by using an inverted microscope, wherein the phagocytes have larger volume and irregular morphology. The cytoplasm is rich, the color is light pink, and the cytoplasm is rich in particles and a few vacuoles. The nucleus blue-purple-red, oval, kidney-shaped or irregular, has typical phagocytic morphological characteristics (fig. 8).
6. Verification of phagocytic function of phagocytes
Chicken erythrocyte phagocytosis assay: culturing 5d 100ul/ml of 10-15% chicken erythrocyte suspension is added into the culture system, the culture is performed in a 24 ℃ incubator for 30 min to 1h, and after PBS flushing, the microscopic examination is performed. Phagocytes phagocyting chicken erythrocytes, a plurality of chicken erythrocytes are visible in the cytoplasm, and the nuclei are squeezed (see fig. 9). The external bacteria invade the phagocytes, the microscopic examination and observation of the turbid culture medium is carried out, the culture medium is continuously placed in a 24 ℃ incubator for culture, and the phagocytes are found to finally phagocytize the bacteria, so that the culture medium becomes clear.
7. Phagocyte chromosome karyotyping
Karyotyping was performed at day 5 of phagocyte culture and chromosome preparation was as follows: colchicine with the concentration of 1ug/ml is added into a culture flask, the culture medium is sucked and removed, PBS is used for flushing, 0.25% pancreatin digestion mixed solution is used for digestion, then the culture medium is added for blowing, phagocytes are tightly attached to the walls, cells which are difficult to digest are scraped by using the cells, then the cell suspension is transferred into a 15ml centrifuge tube, centrifugation is carried out at 1500rpm for 5min, the supernatant is sucked and removed, 5ml of 0.0375M KCl is added, then hypotonic treatment is carried out for 25min in a water bath at 37 ℃, 1ml of newly prepared precooled carnot fixing solution is slowly added, centrifugation is carried out at 1000rpm for min, the supernatant is sucked and removed, 2ml carnot fixing solution is added, ice bath fixing treatment is carried out for 15min, centrifugation at 1000rpm for 5min is repeated twice, 0.2-0.5ml carnot fixing solution is reserved according to the quantity of cells collected by centrifugation after the second fixing, and the glass slide is dripped by a cold dripping method, after drying, dyeing is carried out by 5% Gimsa for 25min, and after drying, oily microscopy is carried out.
Chromosome karyotyping was performed on phagocytes cultured for 5 days, and the number of chromosomes was varied from 28 to 56 among 100 divided phases counted, with 61% of the divided phase chromosomes being 42 (fig. 10), and all of the 42 chromosomes being terminal mitotic chromosomes and containing W-type chromosomes. The number of chromosomes was normally distributed, the frequency of occurrence of diploid chromosome numbers was highest, and the proportion of other aneuploidy was small (FIG. 11).
The foregoing detailed description of the application has been presented for purposes of illustration and description, but is not intended to limit the scope of the application, i.e., the application is not limited to the details shown and described.
Claims (1)
1. A method for culturing phagocytes of fish, characterized in that it comprises the steps of isolation and culture of monocytes, identification of the function of the monocyte body and induction of monocytes as phagocytes,
wherein the isolation and culture of monocytes comprises the steps of:
s1, extracting peripheral blood of fish, and uniformly diluting and mixing whole blood with Hank' S buffer solution in a ratio of 1:2.5-1:3 to obtain diluted blood;
s2, taking lymphocyte separating liquid with the weight 1.5 times of that of diluted blood and the specific gravity 1.05-1.09, and mixing the lymphocyte separating liquid with the blood in a centrifuge tube;
s3, centrifuging for 18-21min at 1800-2100rpm of a horizontal centrifuge, and collecting a mononuclear cell layer;
s4, adding 4-5 times of Hank' S buffer solution to wash for 2 times, centrifuging at 900-1100rpm for 5min, and collecting cell sediment;
s5, re-suspending in a DMEM complete culture medium, inoculating in a culture flask, and placing in a 24 ℃ incubator for culturing for 3 hours; s6, washing the supernatant with Hank' S buffer solution, and adding fresh culture medium to continue culturing the adherent cells;
s7, centrifuging to obtain a monocyte layer, namely lymphocyte and monocyte;
s8, re-suspending the separated mononuclear cells in a complete DMEM medium containing 10-15% of fetal calf serum and added with an adherence promoting growth factor bFGF;
s9, culturing for 2-4 hours, and washing away suspended lymphocytes to obtain adherent mononuclear cells;
the steps of inducing monocytes to phagocytes are as follows:
s1, adding 5-10% of lymphocytes in a complete DMEM culture medium containing mononuclear cells and 15% of fetal calf serum;
s2, changing fresh DMEM complete medium for half a day, and culturing for 3-12 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610775091.5A CN106434558B (en) | 2016-08-31 | 2016-08-31 | Method for separating, culturing and verifying functions of fish mononuclear/phagocyte |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610775091.5A CN106434558B (en) | 2016-08-31 | 2016-08-31 | Method for separating, culturing and verifying functions of fish mononuclear/phagocyte |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106434558A CN106434558A (en) | 2017-02-22 |
CN106434558B true CN106434558B (en) | 2023-10-31 |
Family
ID=58091770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610775091.5A Active CN106434558B (en) | 2016-08-31 | 2016-08-31 | Method for separating, culturing and verifying functions of fish mononuclear/phagocyte |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106434558B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110714048A (en) * | 2019-11-15 | 2020-01-21 | 集美大学 | Screening method of plant-derived immunity-enhanced feed additive for eels |
CN114657125B (en) * | 2022-04-29 | 2023-08-08 | 中国科学院海洋研究所 | Method for separating single nucleus cell of shark, dilution of shark and use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012014156A2 (en) * | 2010-07-26 | 2012-02-02 | Assistance Publique - Hopitaux De Paris | Diagnosis of bacterial meningitis based on the measure of ros production in a sample of cerebrospinal fluid |
CN102533651A (en) * | 2012-01-20 | 2012-07-04 | 中国海洋大学 | Pseudosciaena crocea head kidney macrophage separation and primary culture method and application thereof |
CN105349490A (en) * | 2015-10-29 | 2016-02-24 | 安徽农业大学 | Separating and culturing methods and induction medium of chicken functional macrophage |
-
2016
- 2016-08-31 CN CN201610775091.5A patent/CN106434558B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012014156A2 (en) * | 2010-07-26 | 2012-02-02 | Assistance Publique - Hopitaux De Paris | Diagnosis of bacterial meningitis based on the measure of ros production in a sample of cerebrospinal fluid |
CN102533651A (en) * | 2012-01-20 | 2012-07-04 | 中国海洋大学 | Pseudosciaena crocea head kidney macrophage separation and primary culture method and application thereof |
CN105349490A (en) * | 2015-10-29 | 2016-02-24 | 安徽农业大学 | Separating and culturing methods and induction medium of chicken functional macrophage |
Non-Patent Citations (6)
Title |
---|
Fish peripheral blood mononuclear cells preparation for future monitoring applications;Marie-Aline Pierrard等;《Analytical Biochemistry》;20120410;第426卷;第153-165页 * |
免疫增强剂对牙鲆(Paralichthys Olivaceu)免疫力和抗病力的影响;王正丽;《中国优秀博硕士学位论文全文数据库(博士) 农业科技辑》;20050315;摘要,第三章 * |
牙鲆(Paralichthys olivaceus)外周血单个核细胞的离体培养和电生理特征研究;王彬等;《海洋与湖沼》;20080531(第03期);提要,第1.2、2.1-2.2节 * |
王彬等.牙鲆(Paralichthys olivaceus)外周血单个核细胞的离体培养和电生理特征研究.《海洋与湖沼》.2008,(第03期), * |
鱼类吞噬细胞和吞噬作用的研究进展;刘敏等;《鲁东大学学报(自然科学版)》;20100415(第02期);第167-172页 * |
鲫、草鱼外周血中淋巴细胞和单核细胞对鲤血管内皮细胞的粘附;吴康等;《中国水产科学》;20010712(第02期);第28-31页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106434558A (en) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112251406B (en) | Exosome sorting method in NK cell activation stage | |
CN107557331B (en) | Method for separating and culturing human adipose-derived stem cells | |
CN106434558B (en) | Method for separating, culturing and verifying functions of fish mononuclear/phagocyte | |
CN109294974B (en) | Carassius auratus gibelio spinal cord tissue cell line as well as construction method and application thereof | |
CN116376828B (en) | Method for inducing CD4+ T cells to generate Treg cells and application | |
CN112029717A (en) | Serum-free in vitro domestication culture of human mesenchymal stem cells | |
Chai et al. | Dedifferentiation of human adipocytes after fat transplantation | |
CN108486039B (en) | Method for inducing human adipose-derived stem cells to differentiate into testicular interstitial cells by using small molecules | |
CN107312751B (en) | Special culture medium and culture method for inducing stable differentiation of mouse bone marrow cells into immature dendritic cells | |
CN111718901B (en) | High-activity T cell in-vitro culture kit and culture method | |
CN110857435B (en) | Culture medium for culturing immune cells separated from cord blood and culture method thereof | |
WO2016143808A1 (en) | Method for producing spheroids and culture medium used in method | |
CN106676056A (en) | Method for inducing differentiation from umbilical cord mesenchymal stem cells to insulin secretion cells | |
CN111154721B (en) | NK cell amplification method | |
Pisciolaro et al. | Tooth tissue engineering: the importance of blood products as a supplement in tissue culture medium for human pulp dental stem cells | |
CN108753714B (en) | GSK-3 beta inhibitor induces the purposes of human body Breg cell and the method for separation and induction Breg cell in vitro | |
RU2418855C1 (en) | Medium for cultivation of multipotent stromal cells from human adipose tissue and method of cultivation of said cells with its application | |
KR101440102B1 (en) | Manufacturing method of strong antigen-presenting cells using hydrogel coating and electroporation | |
CN111979192A (en) | Establishment method of co-culture body, co-culture body obtained through establishment and application of co-culture body | |
CN111394301A (en) | Application of piceatannol in increasing number of secreted exosomes of pluripotent stem cells and bioactivity | |
CN107630000B (en) | Kit for separating and culturing peripheral blood-derived macrophages of livestock | |
UA76372C2 (en) | Method for producing cytological preparation of dendritic cells | |
CN115006350B (en) | Construction of milk fat plastid and application thereof in macrophage immunocompetence regulation | |
CN102634483A (en) | In vitro culture method for inducing human umbilical cord blood cells CD34+ to differentiate into Langerhans cell | |
CN108753685B (en) | Separation, screening, culture and function identification method of human aortic vessel wall stem cells expressing c-Kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |